Because IFNs are a key pathogenic factorin lupus, our data suggest that, in the presence of virus infection, theCD20-antibody-mediated enhancement of IFN production might be related to itsfailure in lupus treatments. The gene discussed is IFNA1; the disease is viral infectious disease.